Official Title: A Pilot Study for Quantifying New Heart Muscle Cells
Status: SUSPENDED
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Re-initiating study start up activities at new institution Weill Cornell Medicine
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Regenerative therapies could provide new ways of treating heart failure Unlike many organs in the human body such as the skin and the GI tract the ability to regenerate heart muscle decreases after birth but the precise timing of this decrease and how this decrease is altered in heart disease are uncertain The investigators will use an innovative approach to quantify cellular heart regeneration in pediatric patients an appropriate population for determining this decline as well as the potential for reactivating heart muscle regeneration
The study has now been registered on ClinicalTrialsgov despite its initiation on July 23 2015 as registration was not mandated at the original study site the University of Pittsburgh Medical Center However following the transfer of the study to Weill Cornell Medicine adherence to institutional requirements necessitated its registration on ClinicalTrialsgov